Cefazolin sodium and Gliclazide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cefazolin sodium (cefazolin sodium) and Gliclazide (gliclazide). Common drug interactions include deep vein thrombosis among females and dermatitis bullous among males.

The phase IV clinical study analyzes what interactions people have when they take Cefazolin sodium and Gliclazide. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Cefazolin sodium?

Cefazolin sodium has active ingredients of cefazolin sodium. eHealthMe is studying from 3,649 Cefazolin sodium users. Check the latest studies of Cefazolin sodium.

What is Gliclazide?

Gliclazide has active ingredients of gliclazide. It is often used in diabetes. eHealthMe is studying from 28,131 Gliclazide users. Check the latest studies of Gliclazide.



On Jul, 16, 2026

16 people who take Cefazolin sodium and Gliclazide together, and have interactions are studied.

Cefazolin sodium and Gliclazide drug interactions.

What are the common drug interactions of Cefazolin Sodium and Gliclazide, by gender? *:

female:

  1. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  2. Back pain
  3. Blood pressure increased
  4. Contusion (a type of hematoma of tissue in which capillaries)
  5. Dehydration (dryness resulting from the removal of water)
  6. Disseminated intravascular coagulation (systemic activation of blood coagulation)
  7. Escherichia urinary tract infection (urinary tract infection by escherichia coli)
  8. Fall
  9. Heart rate increased
  10. Hyperthermia malignant (disease passed down through families that causes a fast rise in body temperature (fever) and severe muscle contractions)

male:

  1. Dermatitis bullous (inflammation of the skin characterized by the presence of bullae which are filled with fluid)
  2. Syncope (loss of consciousness with an inability to maintain postural tone)
  3. Renal cyst (kidney cyst)
  4. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  5. Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)
  6. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  7. Bacterial test positive
  8. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  9. Colitis (inflammation of colon)
  10. Constipation

What are the common drug interactions of Cefazolin Sodium and Gliclazide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Fall
  2. Syncope (loss of consciousness with an inability to maintain postural tone)
  3. Renal cyst (kidney cyst)
  4. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  5. Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)
  6. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  7. Back pain
  8. Bacterial test positive
  9. Blood pressure increased
  10. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)

What are the existing conditions these people have? *

  1. High Blood Pressure: 5 people, 31.25%
  2. Cellulitis (infection under the skin): 4 people, 25.00%
  3. Perioperative Analgesia: 3 people, 18.75%
  4. Procedural Hypotension: 3 people, 18.75%
  5. General Anaesthesia: 3 people, 18.75%
  6. Endocarditis (inflammation in heart muscle): 3 people, 18.75%
  7. Type 2 Diabetes: 3 people, 18.75%
  8. Chronic Kidney Disease: 2 people, 12.50%
  9. Dyslipidaemia (abnormal amount of lipids): 2 people, 12.50%
  10. Hypotension (abnormally low blood pressure): 2 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Cefazolin sodium and Gliclazide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Cefazolin sodium and Gliclazide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cefazolin sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Gliclazide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cefazolin sodium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Gliclazide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on cefazolin sodium and gliclazide (the active ingredients of Cefazolin sodium and Gliclazide, respectively), and Cefazolin sodium and Gliclazide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: